Treatment | Pathways | P-value | Genes in Pathway |
---|---|---|---|
Falcarinol | Threonine biosynthesis | 5.3E-05 | MSMEG 6286, thrC, thrB, MSMEG 4957, asd, MSMEG6257 |
Ectoine biosynthesis | 6.1E-05 | asd, MSMEG 6257, ectC, ectA, ectB | |
Superpathway of methionine biosynthesis (by sulfhydrylation) | 4.4E-04 | MSMEG 4528, metE, metX, MSMEG 1652, MSMEG 4657, asd, MSMEG 6257, MSMEG 6286 | |
Isoleucine biosynthesis I | 4.4E-04 | ilvA, ilvH, thrC, thrB, MSMEG 4657, asd, MSMEG 6257, MSMEG 6286 | |
Methionine Biosynthesis | 2.0E-03 | metE, MSMEG 4957, asd, MSMEG 6257, MSMEG 6286, MSMEG 4528, metX, MSMEG 1652 | |
Mycolyl-arabinogalactan-peptidoglycan complex biosynthesis | 2.1E-03 | MSMEG 6386, MSMEG 6399, MSMEG 6382, MSMEG 6401, glf, MSMEG 4947 | |
Homoserine biosynthesis | 3.0E-03 | MSMEG 4957, asd, MSMEG 6257 | |
Superpathway of methionine biosynthesis (transsulfuration) | 4.7E-03 | metE, MSMEG 4957, asd, MSMEG 6257, MSMEG 6286 | |
Unusual Fatty Acid Biosynthesis | 5.5E-03 | MSMEG 1350, MSMEG 1351, MSMEG 3538 | |
Cyclopropane Fatty Acids Biosynthesis | 9.3E-03 | MSMEG 1350, MSMEG 1351, MSMEG 3538 | |
Panaxydol | Ectoine biosynthesis | 3.8E-03 | MSMEG 6257, ectC, ectA, ectB |
Urea degradation II | 3.8E-03 | MSMEG 1093, ureC, ureB, ureA | |
Pyruvate fermentation to acetate VII | 5.1E-03 | pta, ackA, MSMEG 4646 | |
Pyruvate fermentation to acetate I | 5.1E-03 | pta | |
Methionine Biosynthesis | 6.3E-03 | metE, metN, MSMEG 6257, MSMEG 6286, MSMEG 4528, MSMEG 4527, metXm MSMEG 1652 | |
Superpathway of methionine biosynthesis (by sulfhydrylation) | 7.7E-03 | MSMEG 4528, MSMEG 4527, metE, metX, MSMEG 1652, MSMEG 6257, MSMEG 6286 | |
Unusual Fatty Acid Biosynthesis | 9.7E-03 | MSMEG 1205, MSMEG 1350, MSMEG 1351, MSMEG 3538 | |
Cyclopropane Fatty Acids Biosynthesis | 9.7E-03 | MSMEG 1205, MSMEG 1350, MSMEG 1351, MSMEG 3538 | |
Urate biosynthesis/inosine 5′-phosphate degradation | 9.7E-03 | MSMEG 1701, MSMEG 4308, guaB, MSMEG 1603 |